{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T01:56:50Z","timestamp":1784339810400,"version":"3.55.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.clinthera.2009.08.016","type":"journal-article","created":{"date-parts":[[2009,10,6]],"date-time":"2009-10-06T08:47:47Z","timestamp":1254818867000},"page":"1747-1753","source":"Crossref","is-referenced-by-count":17,"title":["Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: A 12-week, randomized, double-blind, placebo-controlled, exploratory study"],"prefix":"10.1016","volume":"31","author":[{"given":"Jonathan D.","family":"Adachi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafat Y.","family":"Faraawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.J.","family":"O\u2019Mahony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Nayar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachid","family":"Massaad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith K.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Yacik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2009.08.016_bib1","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s001980070066","article-title":"Vertebral fracture definition from population-based data: Preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos)","volume":"11","author":"Jackson","year":"2000","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.clinthera.2009.08.016_bib2","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.4065\/77.10.1031","article-title":"Oral bisphosphonates and upper gastrointestinal tract problems: What is the evidence?","volume":"77","author":"Cryer","year":"2002","journal-title":"Mayo Clin Proc."},{"key":"10.1016\/j.clinthera.2009.08.016_bib3","first-page":"253","article-title":"Disintegration and esophageal irritation profiles of alendronate formulations: Implications for clinical safety and efficacy","volume":"5","author":"Epstein","year":"2005","journal-title":"J Appl Res."},{"key":"10.1016\/j.clinthera.2009.08.016_bib4","first-page":"51","article-title":"The clinical tolerability profile of alendronate","volume":"101","author":"Watts","year":"1999","journal-title":"Int J Clin Pract Suppl."},{"key":"10.1016\/j.clinthera.2009.08.016_bib5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1185\/030079904125003548","article-title":"Upper gastrointestinal and overall tolerability of alendronate once weekly in patients with osteoporosis: Results of a randomized, double-blind, placebo-controlled study [published correction appears in Curr Med Res Opin. 2004;20:575]","volume":"20","author":"Eisman","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2009.08.016_bib6","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1185\/030079903125002577","article-title":"Disintegration\/dissolution profiles of copies of Fosamax (alendronate) [published correction appears in Curr Med Res Opin. 2004;20:575]","volume":"19","author":"Epstein","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2009.08.016_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1345\/aph.1H218","article-title":"Brand versus generic alendronate: Gastrointestinal effects measured by resource utilization","volume":"41","author":"Halkin","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2009.08.016_bib8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ejps.2007.03.012","article-title":"Comparative in vitro study of oesophageal adhesiveness of different commercial formulations containing alendronate","volume":"31","author":"Shakweh","year":"2007","journal-title":"Eur J Pharm Sci"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809002999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809002999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,16]],"date-time":"2018-12-16T05:54:01Z","timestamp":1544939641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291809002999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":8,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0149291809002999"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2009.08.016","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}